Published in Medical Letter on the CDC and FDA, September 21st, 2008
The researchers found that the molecule LED209 interferes with the biochemical signals that cause bacteria in our bodies to release toxins.
"What we have here is a completely novel approach to combating illness," said Dr. Vanessa Sperandio, associate professor of microbiology and biochemistry at UT Southwestern and senior author of a study available online today and in a future issue of Science.
Though many antimicrobial drugs are already available, new...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.